Investigators study Pioglitazone and Vitamin E for treatment of NASH

Links shared publicly online about this topic.

1,206
total visits

Investigators study Pioglitazone and Vitamin E for treatment of NASH

A daily dose of a specific form of vitamin E significantly improved the liver disease, nonalcoholic steatohepatitis, according to a study funded by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health. Results were published April 28 online in the New England Journal of Medicine.

View full resource at news-medical.net

Tags: Diabetes Type 2 Medication, Diabetes Medication, Obesity, Vitamin, Supplement, Actos, News

Most Recently Shared on April 29, 2010 at 6:36 am By:

News-Medical.Net

Obesity News: Investigators study Pioglitazone and Vitamin E for treatment of NASH: A daily dose of a specific f... http://twurl.nl/7khdyx

2 years ago...

Retweet

Favorite

Encouraging Findings Suggest New Avenues for Treating Liver Disease in Overweight Americans

newswise.com — “A progressive form of non-alcoholic fatty liver disease (NAFLD) known as non-alcoholic steatohepatitis (NASH) can lead to cirrhosis and all its complications. Two studies investigated the effectiveness of potential treatments for NASH, one assessing pentoxifyline, a commonly used TNF antagonist, as well as a separate analysis of pioglitazone, an insulin sensitizer, compared to vitamin E.” View full resource at newswise.com